Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortWeekly tablet that strengthens bones.Twice-yearly bone-strengthening injection.
Body systemHormones & BonesHormones & Bones
Drug classBisphosphonatesRANKL inhibitors
SupplyPrescription onlyPrescription only
Main usesOsteoporosis, Steroid-induced osteoporosis, Paget's diseaseOsteoporosis, Bone loss from hormone cancer treatment, Preventing fractures from bone metastases
How it worksSlows the cells that break bone down, so bone becomes denser.Blocks the signal that switches on bone-dissolving cells.
Starts working——
Half-lifeOver 10 years in boneAbout 26 days
Typical adult dose70 mg once a week.Osteoporosis: 60 mg under the skin every 6 months.
FormsTablet, Effervescent tablet, Oral solutionPre-filled syringe
Common side effectsHeartburn, Stomach pain, Muscle and bone achesJoint and muscle pain, Back pain, Eczema
Serious side effectsOesophageal ulcers, Jaw osteonecrosis (rare), Atypical thigh fractures (rare, long-term use)Low calcium (severe in advanced kidney disease), Rebound spinal fractures if doses are missed, Jaw osteonecrosis (rare)
Don't take ifOesophageal problems (strictures, achalasia); Cannot sit or stand upright for 30 minutes; Low calcium; Severe kidney impairment (eGFR below 35)—
AlcoholBest to limit. Alcohol irritates the gullet and bones.—
PregnancyUsually avoidedNot used.Usually avoidedContraindicated.
BreastfeedingUsually avoidedAvoid.—
In use since19952010
Brand namesUnited States: Fosamax, BinostoUnited Kingdom: FosamaxIndia: Osteofos, DensicalUnited States: Prolia, Xgeva, Jubbonti (biosimilar)United Kingdom: Prolia, XgevaIndia: Prolia, Denosure
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H—
ATC codeM05BA04M05BX04

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker